MENU
+Compare
TEVA
Stock ticker: NYSE
AS OF
Jul 3 closing price
Price
$17.01
Change
-$0.04 (-0.23%)
Capitalization
15.06B

TEVA Teva Pharmaceutical Industries Limited Forecast, Technical & Fundamental Analysis

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world... Show more

TEVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for TEVA with price predictions
Jul 03, 2025

TEVA sees its Stochastic Oscillator ascends from oversold territory

On July 02, 2025, the Stochastic Oscillator for TEVA moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 60 instances where the indicator left the oversold zone. In of the 60 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

TEVA moved above its 50-day moving average on July 02, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TEVA advanced for three days, in of 286 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 03, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on TEVA as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for TEVA turned negative on May 30, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TEVA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TEVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TEVA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.077) is normal, around the industry mean (62.813). P/E Ratio (22.624) is within average values for comparable stocks, (89.433). Projected Growth (PEG Ratio) (1.594) is also within normal values, averaging (2.987). Dividend Yield (0.000) settles around the average of (0.124) among similar stocks. P/S Ratio (0.982) is also within normal values, averaging (19.290).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

View a ticker or compare two or three
TEVA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

TEVA is expected to report earnings to rise 21.92% to 63 cents per share on July 30

Teva Pharmaceutical Industries Limited TEVA Stock Earnings Reports
Q2'25
Est.
$0.63
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.06
The last earnings report on May 07 showed earnings per share of 51 cents, beating the estimate of 47 cents. With 5.55M shares outstanding, the current market capitalization sits at 15.06B.
A.I.Advisor
published Dividends

TEVA paid dividends on December 12, 2017

Teva Pharmaceutical Industries Limited TEVA Stock Dividends
А dividend of $0.09 per share was paid with a record date of December 12, 2017, and an ex-dividend date of November 27, 2017. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Generic
Address
124 Dvora HaNevi’a Street
Phone
+972 39148213
Employees
37851
Web
https://www.tevapharm.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QSML27.180.21
+0.77%
WisdomTree U.S. Small Cap Quality Gr
QQQE99.450.74
+0.75%
Direxion NASDAQ-100® Equal Wtd ETF
OCTU26.520.18
+0.70%
AllianzIM U.S. Equity Buffer15 UncOctETF
FDCF44.350.30
+0.68%
Fidelity Disruptive Communications ETF
FEP47.850.20
+0.42%
First Trust Europe AlphaDEX® ETF

TEVA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TEVA has been loosely correlated with AMRX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if TEVA jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TEVA
1D Price
Change %
TEVA100%
-0.23%
AMRX - TEVA
38%
Loosely correlated
+0.60%
PCRX - TEVA
28%
Poorly correlated
+0.04%
VTRS - TEVA
27%
Poorly correlated
-0.21%
ELAN - TEVA
27%
Poorly correlated
-0.54%
TLRY - TEVA
27%
Poorly correlated
+11.03%
More